Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma

NCT01882231 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT01882231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01882231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2013
Completion date
April 25, 2016
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ewing sarcoma, osteosarcoma, paget's disease